NOT FOR DISTRIBUTION TO THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, BC / ACCESSWIRE / June 7, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that it intends to complete a non-brokered private placement financing (the "Private Placement") consisting of a maximum of 120,000,000 Units, at a price of $0.015 per Unit, for gross proceeds of a maximum of $1,800,000.

Each Unit shall consist of one common share in the capital of the Company ("Share") and one Share purchase warrant ("Warrant"), with each Warrant entitling the holder thereof to purchase a Share at an exercise price of $0.05 for a period of five years from the date of issuance.

There is an offering document dated June 7, 2024 (the "Offering Document") related to the Private Placement that can be accessed under the Company's profile at and on the Company's website at

This offering document contains additional detail regarding the Private Placement, including additional detail regarding the expected use of proceeds from the Private Placement. Prospective investors should read this offering document before making an investment decision.

As disclosed in the Offering Document, the Company intends to use the net proceeds from the Private Placement to fund additional capital improvements at the Company's existing facilities and for general administrative and working capital expenses.

The Units offered as a part of the Private Placement shall be offered to purchasers' resident in all provinces of Canada, including Quebec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the "Listed Issuer Financing Exemption"). Units offered under the Listed Issuer Financing Exemption will not be subject to resale restrictions to Canadian resident investors pursuant to applicable Canadian securities laws.

The Private Placement is anticipated to close on or about July 22, 2024, or such later date as the Company may determine. The closing is subject to certain conditions including the receipt of all necessary regulatory and other approvals, including the Company's completion of its filing obligations under the policies of the CSE.

As disclosed in the Offering Document, the Company may pay finder's fees under the Private Placement as permitted by CSE policy and applicable securities laws.

The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any U.S. state securities laws, and may not be offered or sold in the United States absent registration or available exemptions from such registration requirements. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States, or in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Paul Rosen, Chairman and CEO of the Company commented, "The Company is raising capital and reviewing various strategic options, including, M&A activity, the sale of certain Company assets, and a shift in business focus. These actions are being undertaken to position the Company well for the anticipated rescheduling of cannabis. While operating as a pure wholesale enterprise in Nevada is challenging, in May, Headset business intelligence recognized the AMA brand as Nevada's top selling concentrate brand, second top selling flower brand and third top selling pre-roll brand, based upon total revenue."

The Company also announces that its General Counsel and Vice President, Mr. Caleb Zobrist's employment agreement has ended in accordance with the term specified therein. The Company thanks Mr. Zobrist for his many contributions over his tenure and wishes him well in his future endeavours.

About 1933 Industries Inc.

1933 Industries is a Nevada-based licensed producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company's 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit .

For further information please contact:

Alexia Helgason, VP, IR
604-728-4407
alexia@1933industries.com

Paul Rosen, CEO
paul@1933industries.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on . 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: 1933 Industries Inc.